secwatch.observer — SEC 8-K summary
======================================

Issuer:     QuidelOrtho Corp (QDEL)
CIK:        0001906324
Form:       8-K12B/A
Filed at:   2022-08-10T23:59:59+00:00
Accession:  0001906324-22-000015
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

QuidelOrtho reports pro forma combined revenue of $2.4B and net income of $489.9M for H1 2022
--------------------------------------------------------------------------------

- Pro forma combined revenue for six months ended July 3, 2022: $2.4B; net income $489.9M; diluted EPS $7.22.
- Pro forma combined revenue for year ended Jan 2, 2022: $3.74B; net income $619.1M; diluted EPS $9.08.
- Acquisition of Ortho Clinical Diagnostics closed May 27, 2022; total purchase consideration ~$4.3B.
- Ortho shareholders received $7.14 cash + 0.1055 shares per Ortho share; $2.5B in stock and $1.75B cash paid.
- Preliminary purchase price allocation: $3.13B intangible assets, $2.29B goodwill, $767.5M PP&E.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1906324/000190632422000015/0001906324-22-000015-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1906324/000190632422000015/qdel-20220527.htm
  HTML page:      https://secwatch.observer/filing/0001906324-22-000015

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer